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 Abstract
We present a case of pregnancy in 28-years old nulliparous woman with an over 20-years long history of diabetes, 
hypothyroidism, diabetic nephropathy with nephrotic syndrome, retinopathy and coronary artery disease treated 
with PCA prior the pregnancy (class H diabetes, according to White classification). 
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 Streszczenie
W pracy przedstawiono przypadek 28 letniej ciężarnej, chorującej na cukrzycę od ponad 20 lat, leczoną także z powodu niedoczyn-
ności tarczycy, nefropatii cukrzycowej z zespołem nerczycowym, która przed ciążą przebyła ostry zespół wieńcowy, 
leczony za pomocą PCA (cukrzyca kl. H wg White).
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A case report
A	28-years	old	female	was	referred	to	our	Department	by	her	
primary	care	gynaecologist	for	further	treatment	in	the	10th week 
of	 an	unplanned	pregnancy.	She	 suffered	 from	 type	1	 diabetes	
since	the	age	of	7	and	remained	within	a	care	of	a	local	diabetes	
outpatient	unit.	Being	21	years	old,	 the	patient	was	 referred	 to	
a	 tertiary	level	academic	centre	for	diabetic	patients	for	further	
evaluation	and	treatment	because	of	poor	metabolic	control,	but	
she	did	not	accept	offered	intensive	insulin	therapy.	At	the	age	of	
22	she	was	diagnosed	with	simple	retinopathy.	Diabetic	kidney	
disease	was	diagnosed	a	year	 later	because	of	proteinuria.	She	
has	 had	 recurrent	 urinary	 tract	 infections	 but	 kidney	 function	
before	 pregnancy	 was	 not	 evaluated.	 Being	 26-years	 old,	 the	
patient	developed	arterial	hypertension	and	was	diagnosed	with	
hypothyreosis	–	treatment	with	ACE-inhibitors	and	thyroxine	was	
introduced.	In	the	same	year,	she	had	acute	myocardial	infarction	
and	required	PCA	and	stenting	of	the	right	coronary	artery.	
She	 used	 to	 be	 a	 poorly	 cooperative	 individual,	 reporting	
irregularly	for	follow-up	visits.	She	also	discontinued	medication	
on	her	own	and	did	not	follow	recommendations	concerning	diet,	
insulin	 therapy	 and	 smoking	 cessation.	 Several	 years	 prior	 to	
the	cardiac	ischemic	event	she	used	oral	contraceptives	against	
diabetologists’	 recommendations.	 During	 the	 last	 two	 years	
preceding	her	pregnancy,	she	did	not	appear	for	a	follow-up	at	all	
and	no	data	on	her	status	was	available.	
During	the	first	antenatal	hospitalisation	in	our	Department,	
we	 confirmed	 pregnancy	 and	 recalculated	 her	 gestational	
age:	 according	 to	 our	 ultrasonic	 scan	 that	was	 the	 first	 one	 in	
her	 pregnancy.	 The	 patient	 was	 diagnosed	 to	 be	 at	 7th	 weeks’	
gestation	(GA	7).	We	obtained	full	range	of	metabolic	parameters	
and	 checked	 her	 renal	 function	 	 (patient’s	 gestational	 data	 is	
summarised	in	Table	I).	
As	 she	 wished	 to	 continue	 the	 pregnancy,	 we	 arranged	
additional	 consultations	 of	 a	 nephrologist	 and	 cardiologist.	
Echocardiography	 did	 not	 reveal	 any	 changes	 in	 myocardium	
function	 and	 minimal	 mitral	 valve	 insufficiency.	 Her	 thyroid	
function	was	properly	controlled.	
During	the	first	hospitalisation,	we	focused	on	improvement	
in	 treatment	 and	 current	 metabolic	 control.	 The	 patient	 was	
offered	 intensified	 training	with	 special	 attention	 to	 control	 of	
fluid	 and	 sodium	 intake,	 blood	glucose	monitoring	 and	 insulin	
self-administration.	 She	 switched	 from	 multiple	 daily	 insulin	
injections	 to	 insulin	 pump	 therapy.	 Apart	 from	 this,	 she	 was	
treated	 with	methyldopa	 (3x250/dmg	 –	 4x500mg/d	 at	 the	 end	
of	pregnancy),	bisoprolol	 (2x5	mg/d	 from	 the	second	 trimester	
of	 pregnancy),	 furosemide	 (30-60mg/d),	 Aspirin	 75mg/d	 and	
enoxaparine	 	 (0,4IU/day).	Urinary	 tract	 infections	were	 treated	
with	antibiotics	according	to	results	of	serial	urine	cultures.
During	consecutive	hospitalisations	(GA	10,	GA	14,	GA	18,	
GA	22	and	the	last	stay	in	the	Department	from	the	23rd	week	of	
gestation	to	the	delivery	in	the	33rd	week	of	gestation)	we	focused	
on	monitoring	of	patient’s	general	status	with	a	particular	attention	
paid	to	maintaining	improved	metabolic	control,	antihypertensive	
therapy	and	monitoring	renal	function	that	proved	to	be	difficult	
mainly	 due	 to	 recurrent	 urinary	 tract	 infections	 with	 massive	
bacteriuria	 and	 proteinuria.	 Her	 metabolic	 control	 improved	
from	the	11th	week	of	gestation	(HbA
1c
	range	between	6.7%	and	
5.5%).	
Due	 to	 retinopathy	 deterioration,	 patient	 underwent	 two	
series	of	photocoagulation,	in	the	16th	and	18th	week	of	gestation.	
As	 she	 developed	 anaemia	 resistant	 to	 iron	 supplementation,	
erythropoietin	 (1000	 IU/	 once	 a	week)	was	 commenced	 in	 the	
22nd	 gestational	 week.	 Urinary	 protein	 excretion	 decreased	 at	
GA	11	but	then	increased	continuously,	with	a	decrease	in	total	
serum	protein	level,	alterations	in	lipid	profile	characteristic	for	
nephrotic	 syndrome	 (with	 a	 total	 cholesterol	 up	 to	 515mg/dl	
and	 triglycerides	up	 to	360	mg/dl)	 and	massive	oedema.	From	
gestational	age	of	26	weeks	on,	serum	creatinine	concentration	
increased	 and	 reached	 1.6mg/dl	 at	 30th	 week	 of	 gestation.	
Creatinine	clearance	decreased	 to	59mL/min	at	32nd	week.	 	To	
maintain	 renal	 function	 and	 reduce	 oedema,	 the	 patient	 was	
given	fresh	frozen	plasma	preparations	from	11th	week	and	at	24th 
week	methylprednisolone	4mg	once	a	day	was	added	to	reduce	
increasing	proteinuria.	
During	 the	 last	 trimester,	 we	 also	 instituted	 measurement	
of	 body	mass	 once	 a	 week	 and	 daily	 fluid	 intake	 and	 output,	
due	to	massive	oedema.	Because	of	serious	maternal	condition,	
we	 arranged	 regular	 consultations	 of	 nephrologist	 and	
ophthalmologist.
We	also	strictly	monitored	foetal	wellbeing	using	serial	USG	
with	Doppler	examination	and	CTG	from	the	26th	week	of	gesta-
tion	on.	Detailed	foetal	scanning	both	in	the	first	and	in	the	sec-
ond	trimester	revealed	no	foetal	malformations	and	foetal	growth	
adequate	 to	 a	 gestational	 age.	From	 the	26th	week	onward,	we	
assessed	 foetal	wellbeing	 and	 development	 once	 a	week	 using	
greyscale	and	Doppler	examination	and	non-stress	tests.	
At	GA	32,	due	to	further	deterioration	in	renal	function,	we	
decided	 to	 perform	 cesarean	 section.	After	 administration	 of	 a	
total	dose	of	24mg	betamethasone	to	improve	fetal	lung	maturity,	
she	 delivered	 an	 immature	 son	 weighting	 1550g;	 the	 Apgar	
score	was	6	and	7	at	1	and	5 minute,	respectively.	The	newborn	
required	a	hospitalization	in	the	NICU	until	the	32nd	day	of	life	
for	treatment	of	a	mild-grade	RDS	and	neonatal	sepsis.	He	was	
discharged	home	in	a	good	condition.	
In	 the	13th	 day	of	 puerperium,	due	 to	 further	 deterioration	
in	 renal	 function,	 the	 patient	 was	 transferred	 to	 Department	
of	 Nephrology	 of	 our	 University	 for	 further	 diagnostics	 and	
treatment.	Finally,	two	months	after	the	delivery,	a	renal	biopsy	
was	 performed	 to	find	 out	 a	 reason	 for	 nephrotic	 syndrome	 in	
our	 patient.	 The	 biopsy	 yielded	 9	 glomeruli	 and	 1	 completely	
sclerotized.	 They	 were	 enlarged,	 with	 slightly	 or	 moderately	
increased	cell	number	and	markedly	increased	mesangial	matrix.	
Mesangiolysis	 was	 found	 in	 one	 glomerulus.	 Two	 glomeruli	
demonstrated	 thickened	 afferent	 or	 efferent	 arterioles	 with	
hyalinosis.	 Numerous	 fibrotic	 foci	 and	 lympholytic	 infiltration	
were	 seen	 in	 the	 interstitial	 space.	 Immunofluorescent	 staining	
showed	 diffused	 immunoglobulin	A	 (IgA),	 IgG	 and	 focal	 IgM	
deposits.	The	histopathological	diagnosis	was	glomerulosclerosis	
due	to	IgA	nephropathy	and	diabetic	kidney	disease.
The	 patient	 received	 six	 inravenous	 methylprednisolone	
pulses	 (500mg	 each	 every	 4-6	 weeks),	 followed	 by	 prednison	
30mg/d	 p.o.	 and	 cyclophosphamide	 (1g	 i.v.	 every	 month,	 6	
times).	Two	months	later,	her	blood	pressure	was	130/80mmHg,	
Hb	11.5	g/dL,	RBC	3.7	T/L,	daily	protein	loss	1.9g/24	hrs,	serum	
creatinine	 of	 1.7mg/dL	 and	 estimated	 GFR	 (MDRD)	 54mL/
min/1.73m2.
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Discussion
Diabetic	 vascular	 disease	 is	 commonly	 recognised	 as	
a	 major	 factor	 associated	 with	 impaired	 perinatal	 outcome.	
Different	authors	report	vasculopathy,	particularly	renal	disease	
(nephropathy),	as	a	strong	risk	factor	for	preeclampsia,	iatrogenic	
prematurity	 and	 increased	 maternal	 and	 neonatal	 mortality	
and	morbidity	 [1,	 2,	 3].	Moreover,	 	 ischemic	 heart	 disease	 	 is	
considered	as	a	serious	contraindication	to	pregnancy	itself	and	
all	data	concerning	this	population	of	diabetic	women	is	scarce	
and	many	years	old	[4,	5,	6,	7,	8].	
In	our	patient,	we	report	a	diabetic	pregnancy	complicated	
with	a	proliferative	retinopathy,	ischemic	heart	disease	and	renal	
disease	that	was	initially	diagnosed	as	a	diabetic	nephropathy	due	
to	a	long-lasting	and	poorly	controlled	diabetes.	Early	onset	of	a	
nephrotic	proteinuria	in	our	patient	suggested	coexistence	of	pre-
gestational	diabetic	kidney	disease	(DKD)	and	other	glomerular	
disease.	
Although	 a	 marked	 reduction	 of	 proteinuria	 followed	
improved	 glycemic	 control,	 the	 relapse	 of	 the	 nephrotic	
syndrome	a	few	weeks	later	confirmed	our	primary	hypothesis.	
Throughout	gestation,	we	excluded	such	possible	causes	of	 the	
nephrotic	 syndrome	 as	 lupus	 nephropathy,	 systemic	 vasculitis	
and	 antiphospholipid	 syndrome	 as	 all	 tests	 for	 these	 disorders	
were	 negative.	Small	 dosage	of	methylprednisolone	was	 given	
throughout	 pregnancy,	 to	 inhibit	 worsen	 of	 nephritic	 function.	
This	 steroid	 doesn’t	 cross	 the	 placenta,	 so	 at	 the	 moment	 of	
risk	 of	 premature	 delivery	 we	 decided	 to	 give	 bethamethason	
to	 stimulate	 lung	maturation,	 that	 is	 known	 to	 be	 impaired	 in	
diabetic	pregnancy.
A	primary	glomerular	disease	imposed	on	the	DKD	remained	
as	 the	most	 probable	 cause.	A	 renal	 biopsy	was	 considered	 to	
establish	a	targeted	therapy	as	it	was	demonstrated	that	pregnancy	
itself	does	not	increase	risk	of	complications	for	this	procedure	
[9].	
Table 1. Maternal data throughout gestation.
Maternal 
parameter GA 7
GA 
11
GA 
14
GA 
18
GA 
19
GA 
22
GA 
24
GA 
26
GA 
28
GA 
30
GA 
32
Days postpartum
3 6 11
Average daily 
glycemia 
[mmol/dL]
7.3 6.7 6.4 8.8 6.1 6.1 6.1 6.4 6.7 5.5 6.1
HbA1c [%] 9.7 7.8 6.3 6.1 5.7 6.2 5.8 5.7 5.7 6.1 6.7
Basal insulin 
requirement 
[IU/day]
35 35 21 35 37 37 39 39 40 40 40
Total serum 
protein [g/L] 5.4 4.2 4.4 4.2 4.3 3.9 4.2 4.2 3.7 3.6 3.1 4.1
Serum ureic 
acid [mg/dL] 5.5 4.6 4.8 5.9 4.9 5.7 5.4 6.3 6.3 4.8 5.8
Serum urea 
[mg/dL] 42 47 48 51 55 47 51 62 53 55 67
Creatinine 
[mg/dL] 0.7 0.7 0.9 0.9 1.1 0.9 0.9 1.1 1.3 1.6 1.5 2.0 2.1 2.5
Serum K* 
[mmol/L] 4.9 4.2 4.5 5.6 4.5 4.4 4.6 3.7 4.4 4.5 5.3
GFR [ml/
min/24 hrs] 117 122 65 67 100 96 73 94 82 69 59 37 33 29
Daily 
proteinuria 
[g/24 hrs]
6.1 neg 4.9 4.9 13.7 5.5 9.9 15.4 12.7 20.5 14.3 14.0 20.3 22.1
Triglycerides 
[mg/dL] 116.9 175.1 250.6 439.7 270.6 437.6 341.7 392.5 360.4 337.9
LDL-
cholesterol 
[mg/dL]
122.0 210.6 219.7 352.7 258.3 278.6 265.9 357.8 345.6 277.2 251.2
HDL- 
cholesterol 
[mg/dL]
89.1 111.0 107.6 91.8 107.4 83.5 69.7 106.0 97.4 70.8 38.2
Total 
cholesterol 
[mg/dL]
234.5 356.6 377.4 532.5 457.7 449.6 404.0 542.3 515.0 471.7 357.0
Hb [mmol/L] 7.8 6.6 6.5 6.5 5.2 5.8 5.5 5.8 5.6 5.5 5.5
RBC [T/L] 4.1 3.6 3.4 3.2 2.7 3.0 2,9 3.1 2.9 2.6 2.6
Hct [L/L] 0.37 0.32 0.30 0.28 0.27 0.28 0.26 0.28 0.26 0.26 0.24
Serum Fe 
concentration 
[mcg/dL]
135.6 103.5 99.9 95.0 59.0
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However,	 due	 to	 recurrent	 UTI	 and	 absence	 of	 rapidly	
progressing	 glomerulonephritis	 requiring	 an	 aggressive	
treatment,	the	biopsy	was	postponed	until	after	the	delivery	[10].	
A	recently	published	retrospective	analysis	of	perinatal	outcome	
in	pregnancies	complicated	with	severe	preeclampsia	manifesting	
as	the	nephrotic	syndrome	revealed	that	most	of	women	recovered	
after	 delivery	 but	 authors	 noted	 a	 30%	 perinatal	 mortality	 in	
newborns	and	68%	were	born	with	a	 small	 for	gestational	 age	
birth	weight	 [11].	The	 clinical	 course	 of	 the	 kidney	 disease	 in	
our	patient	 confirms	 the	 suggestion	 that	proteinuria	may	be	 an	
independent	 risk	 factor	 for	 pregnancy	 related	 decline	 in	 renal	
function,	better	that	blood	pressure	or	renal	function	at	baseline	
[12].	The	marked	decline	of	renal	function	in	our	patient	appeared	
at	GA	32	and	was	a	reason	for	early	delivery.	
The	kidney	biopsy	in	our	patient	revealed	focal	and	segmental	
glomerulosclerosis	 due	 to	 IgA	 nephropathy	 and	 changes	
characteristic	 for	DKD.	This	finding	 supports	 the	opinion,	 that	
early	 onset	 nephrotic	 syndrome	 in	 pregnancy,	 even	 in	 patients	
with	diabetes	and	already	diagnosed	DKD	indicates	a	nondiabetic	
chronic	renal	disease	coexisting	(or	not)	with	DKD.	Some	data	
suggest	 that	women	with	 IgA	nephropathy,	 focal	 sclerosis	 like	
those	with	membrano-proliferative	glomerulonephritis	or	reflux	
nephropathy	develop	a	permanent	renal	failure	more	frequently	
than	 those	with	 other	 renal	 disorders	 [10].	Our	 case	 also	 adds	
to	 previous	 observations	 that	 early-onset	 nephrotic	 syndrome	
in	pregnant	woman	with	diabetes	 should	always	be	considered	
as	 a	 symptom	of	 a	 nondiabetic	 kidney	 diseases	 and	 represents	
a	 significant	 challenge	 for	 medical	 care	 providers.	 No	 simple	
recommendations	 can	 be	 given	 in	 any	 particular	 case,	 which	
should	be	managed	by	an	obstetrician	with	a	special	interest	in	a	
high	risk	pregnancy	and	a	nephrologist.
In	our	patient,	we	also	report	a	rare	case	of	pregnancy	in	a	
woman	with	a	 type	II	autoimmune	polyglandular	syndrome.	In	
nonpregnant	population,	TPO	antibodies	are	found	in	14-30%	of	
individuals	with	type	1	diabetes	[13].	Scarce	data	is	available	on	
coexistence	between	thyroid	dysfunction	and	type	1	diabetes	in	
pregnant	women,	reporting	a	prevalence	of	autoimmune	thyroid	
diseases	between	22,5	and	30%	in	this	population	[14,	15].	To	our	
knowledge,	no	data	on	perinatal	outcome	in	women	with	APS-II	
is	available.	Association	between	maternal	autoimmune	thyroid	
dysfunction	and	 fetal	maldevelopment	 is	well	documented	and	
in	our	patient	we	did	not	note	any	perinatal	complications	 that	
could	be	attributed	to	this	condition	[16].	However,	in	our	patient	
thyroid	disease	was	diagnosed	and	treated	prior	to	pregnancy	and	
thyroid	hormones	 remained	within	 reference	values	 throughout	
gestation.	
Surprisingly,	 we	 did	 not	 note	 foetal	 complications	 typical	
for	 diabetic	 nephropathy,	 particularly	 placental	 insufficiency	
manifesting	 as	 an	 intrauterine	 growth	 restriction	 and	 reduced	
amount	 of	 amniotic	 fluid	 (oligohydramios).	 Also	 serial	
Doppler	 examinations	 of	 materno-fetal	 circulation	 showed	 no	
abnormalities	suggestive	of	chronic	foetal	hypoxia	and	non-stress	
tests	performed	in	the	IIIrd	trimester	showed	no	changes	in	foetal	
behaviour	characteristic	for	a	chronic	distress.
We	 also	 did	 not	 observe	 deterioration	 in	maternal	 cardiac	
function,	as	echocardiography	performed	in	the	Ist	and	early	third	
trimester	found	only	slight	impairment	of	cardiac	function	of	no	
haemodynamic	 significance.	We	 presume	 it	 could	 be	 the	most	
important	 factor	 associated	 with	 an	 overall	 positive	 perinatal	
outcome	we	achieved	in	this	complex	case.	
In	our	patient,	we	present	a	model	case	when,	apart	from	a	
very	serious	maternal	condition,	a	good	perinatal	outcome	was	
achieved	thanks	to	increased	maternal	motivation	and	strenuous	
efforts	 of	 a	 multidisciplinary	 team.	 Due	 to	 lack	 of	 pregnancy	
planning	 we	 had	 to	 use	 symptomatic	 treatment.	 Therefore,	
preconception	care	in	such	patients	remains	of	vital	importance	
for	increasing	maternal	and	offspring’s	odds.	
General	 improvement	 in	 a	 quality	 and	 effectiveness	 of	
medical	 care	 in	 diabetic	 patients	 that	 we	 have	 witnessed	 in	
the	 recent	 decades	 results	 in	 longer	 life-expectancy	 and	 better	
quality	 of	 life,	 therefore	 increased	 number	 of	 women	 with	
type	 1	 diabets	 and	 microvascular	 complications	 decides	 to	
give	 birth.	Moreover,	 population	 of	women	with	 diabetes	 also	
mirrors	a	general	trend	of	making	a	decision	on	pregnancy	later	
than	in	previous	generations.	Therefore,	diabetic	care	providers	
have	 to	 be	 prepared	 for	 pregnancy	with	 chronic	microvascular	
complications	 shifting	 from	 rarity	 to	 a	 more	 common	 option.	
Fortunately,	constant	improvement	in	feto-	maternal	and	neonatal	
medicine	allows	us	to	get	good	perinatal	outcome	both	for	mothers	
and	their	children.	
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